Study aim: Determining the effect of Curcumax capsule on postpartum depression Design: A clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 124 patients, randomized permutation block method with block size 6 is used for randomization. Settings and conduct: The research is carried out in Health Center No. 3 of West Ahvaz, which is first identified by screening patients and then randomly entered into intervention and control groups. Uniform envelopes are used in packages and mats containing drugs, which are numbered according to the table of random permutations, and the researcher and sample are blinded. Participants/Inclusion and exclusion criteria: Inclusion criteria: 18-15 years old, first or second pregnancy, literacy, term delivery, healthy baby delivery, low risk pregnancy and no chronic diseases having Exclusion criteria: a history of allergies to herbal medicines, drug addiction, severe depression Intervention groups: People in the intervention group are given Curcumax capsules once a day after lunch and the control group is given a placebo (starch) capsule once a day after lunch for 8 weeks. Main outcome variables: Postpartum Depression